Topics

LogicBio enters $20mm debt facility with Oxford and Horizon; gets $10mm up front

15:40 EDT 12 Jul 2019 | Elsevier Business Intelligence

Gene editing firm LogicBio Therapeutics Inc. entered into a $20mm debt facility with Oxford Finance and Horizon Technology Fi...

Original Article: LogicBio enters $20mm debt facility with Oxford and Horizon; gets $10mm up front

NEXT ARTICLE

More From BioPortfolio on "LogicBio enters $20mm debt facility with Oxford and Horizon; gets $10mm up front"

Quick Search

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...